EBUS was good at differentiating new lung cancer from recurrence
www.pulmccm.org
Anraku et al report a series of 40 patients previously treated for lung cancer who underwent endobronchial ultrasound guided transbronchial needle aspiration for new mediastinal or hilar abnormalities between 2008-2010 at University of Toronto. After EBUS-TBNA of mediastinal/hilar lymph nodes, 28 of 40 were found to have lung cancer. In 21, an identical cell type as their primary cancer suggested recurrence. In 7, the cancer was a new cell type and believed to be a new primary.
EBUS was good at differentiating new lung cancer from recurrence
EBUS was good at differentiating new lung…
EBUS was good at differentiating new lung cancer from recurrence
Anraku et al report a series of 40 patients previously treated for lung cancer who underwent endobronchial ultrasound guided transbronchial needle aspiration for new mediastinal or hilar abnormalities between 2008-2010 at University of Toronto. After EBUS-TBNA of mediastinal/hilar lymph nodes, 28 of 40 were found to have lung cancer. In 21, an identical cell type as their primary cancer suggested recurrence. In 7, the cancer was a new cell type and believed to be a new primary.